United States of America v. Crescendo Bioscience, Inc.
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA 6 UNITED STATES OF AMERICA, et al., Case No. 16-cv-02043-TSH
Plaintiffs,
ORDER RE: MOTION TO DISMISS
v. Re: Dkt. No. 49 CRESCENDO BIOSCIENCE, INC., et al., Defendants.
12 I. INTRODUCTION Plaintiff-Realtor STF, LLC brings this qui tam action on behalf of the United States and the State of California against Defendants Crescendo Bioscience, Inc. and Myriad Genetics, Inc., under the Federal False Claims Act, California False Claims Act, and California Insurance Frauds Prevention Act. Before the Court is Defendants’ Motion to Dismiss STF’s First Amended Complaint (“MTD”), ECF No. 49, which seeks dismissal of STF’s claims pursuant to Federal Rules of Civil Procedure 9(b) and 12(b)(6). The Court finds this matter suitable for disposition without oral argument and VACATES the May 28, 2020 hearing. See Civ. L.R. 7-1(b). Having considered the parties’ positions, relevant legal authority, and the record in this case, the Court DENIES…